These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14768071)

  • 1. Effects of estrogen plus progestin on health-related quality of life.
    Watts NB
    N Engl J Med; 2004 Feb; 350(6):622. PubMed ID: 14768071
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogen plus progestin on health-related quality of life.
    Lopes AA; Latado A; Lopes GB
    N Engl J Med; 2004 Feb; 350(6):622. PubMed ID: 14762196
    [No Abstract]   [Full Text] [Related]  

  • 3. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of estrogen and gestagen substitution in peri and postmenopause].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Jan; 86(5):125-8. PubMed ID: 9064729
    [No Abstract]   [Full Text] [Related]  

  • 5. The sexual health benefits of oral low-dose estrogen plus progestogen and vaginal estrogen for postmenopausal women.
    Kingsberg SA
    Menopause; 2009; 16(2):224-5. PubMed ID: 19188846
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of estrogen-progestin and estrogen on mammographic density.
    Kaewrudee S; Anuwutnavin S; Kanpittaya J; Soontrapa S; Sakondhavat C
    J Reprod Med; 2007 Jun; 52(6):513-20. PubMed ID: 17694969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Substitution therapy with estrogens and gestagens].
    Kuhl H
    Dtsch Med Wochenschr; 1995 May; 120(21):765-8. PubMed ID: 7781501
    [No Abstract]   [Full Text] [Related]  

  • 8. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of dementia in long-term hormone users.
    Petitti DB; Crooks VC; Chiu V; Buckwalter JG; Chui HC
    Am J Epidemiol; 2008 Mar; 167(6):692-700. PubMed ID: 18218608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
    Archer DF
    Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen plus progestin and colorectal cancer in postmenopausal women.
    Grant EC
    N Engl J Med; 2004 Jun; 350(23):2417-9; author reply 2417-9. PubMed ID: 15175448
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.
    Koundi KL; Christodoulakos GE; Lambrinoudaki IV; Zervas IM; Spyropoulou A; Fexi P; Sakkas PN; Soldatos CR; Creatsas GC
    Gynecol Endocrinol; 2006 Dec; 22(12):660-8. PubMed ID: 17162707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.